Remote monitoring for gout in primary care
The Self-management App 'MinUrinsyregikt' for Patients With Gout. The ReMonit Gout Feasibility Study in Primary Care
This project will test a smartphone self-management app to help adults with gout and high urate levels manage their condition alongside GP follow-up.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Diakonhjemmet Hospital Academic / other |
| Locations | 1 site (Oslo) |
| Trial ID | NCT07490522 on ClinicalTrials.gov |
What this trial studies
This is a single-group, decentralized feasibility project in Norway in which 20–50 adults with gout will use the 'MinUrinsyregikt' self-management app for 3 months while receiving usual GP follow-up. Participants will register tophi presence, urate-lowering medication and dose, medication adherence, flares, and monthly serum urate results in the app, which provides reminders and prompts for blood tests and medications. Data will be collected via baseline and 3-month digital questionnaires and through semi-structured interviews with both patients and GPs about their experiences. GPs remain responsible for medical care and will not access app data; the aim is to test feasibility and inform a future randomized controlled trial.
Who should consider this trial
Good fit: Adults (≥18 years) with a clinical gout diagnosis, serum urate >360 µmol/L, an indication for urate-lowering therapy, access to a smartphone or tablet, and the ability to understand Norwegian are ideal candidates.
Not a fit: Patients who are pregnant or breastfeeding, have contraindications to urate-lowering therapy, major comorbidities, or who lack a smartphone or Norwegian language ability are unlikely to benefit from this app-based approach.
Why it matters
Potential benefit: If successful, the app could improve medication adherence and timely serum urate monitoring, leading to better gout control in primary care.
How similar studies have performed: E-health self-management interventions for chronic diseases have shown adherence benefits in some pilots, but digital interventions specifically for gout are limited and lack large randomized trial evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Patients are eligible to be included in the study only if all the following criteria apply: * Adults ≥18 years of age at screening * Patients with a clinical diagnosis of gout * Serum urate level \>360 µmol/L at inclusion * Indication for urate lowering therapy assessed by medical doctor * Having a smartphone/tablet Patients are excluded from the study if any of the following criteria apply: * Pregnant or breastfeeding * Contraindication for urate lowering therapy * Does not understand Norwegian language * Major co-morbidities (e.g., malignancies, severe chronic kidney disease, severe mental disorders)
Where this trial is running
Oslo
- Diakonhjemmet Hospital — Oslo, Norway (Recruiting)
Study contacts
- Principal investigator: Fiona Aanesen — Diakonhjemmet Hospital
- Study coordinator: Fiona Aanesen, PhD
- Email: fiona.aanesen@diakonsyk.no
- Phone: +47 22451500
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.